Literature DB >> 30168074

A rare case of disseminated histoplasmosis in a patient with Crohn's disease on immunosuppressive treatment.

Bhavesh Bhut1, Akshay Kulkarni1, Varnika Rai2, Vinita Agrawal2, Abhai Verma1, Manoj Jain2, Rungmei S K Marak1, Ajai Kumar Dixit3, Uday C Ghoshal4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30168074     DOI： 10.1007/s12664-018-0886-1

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  5 in total

1.  Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series.

Authors:  Jennifer L Dotson; Wallace Crandall; Hayat Mousa; Jonathan R Honegger; Lee Denson; Charles Samson; Dennis Cunningham; Jane Balint; Molly Dienhart; Preeti Jaggi; Ryan Carvalho
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

Review 2.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome.

Authors:  Janak Kishore; Ujjala Ghoshal; Uday C Ghoshal; Narendra Krishnani; Sanjay Kumar; Manisha Singh; Archana Ayyagari
Journal:  J Med Microbiol       Date:  2004-11       Impact factor: 2.472

Review 4.  Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.

Authors:  Dong Il Park; Tadakazu Hisamatsu; Minhu Chen; Siew Chien Ng; Choon Jin Ooi; Shu Chen Wei; Rupa Banerjee; Ida Normiha Hilmi; Yoon Tae Jeen; Dong Soo Han; Hyo Jong Kim; Zhihua Ran; Kaichun Wu; Jiaming Qian; Pin-Jin Hu; Katsuyoshi Matsuoka; Akira Andoh; Yasuo Suzuki; Kentaro Sugano; Mamoru Watanabe; Toshifumi Hibi; Amarender S Puri; Suk-Kyun Yang
Journal:  Intest Res       Date:  2018-01-18

Review 5.  Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication).

Authors: 
Journal:  Intest Res       Date:  2018-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.